BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boutelle AM, Attardi LD. p53 and Tumor Suppression: It Takes a Network. Trends Cell Biol 2021;31:298-310. [PMID: 33518400 DOI: 10.1016/j.tcb.2020.12.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu Q, Zhao J, Guo Y, Liu M, Schinckel AP, Zhou B. A Single-Nucleotide Polymorphism in the Promoter of Porcine ARHGAP24 Gene Regulates Aggressive Behavior of Weaned Pigs After Mixing by Affecting the Binding of Transcription Factor p53. Front Cell Dev Biol 2022;10:839583. [DOI: 10.3389/fcell.2022.839583] [Reference Citation Analysis]
2 Labrie M, Brugge JS, Mills GB, Zervantonakis IK. Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer. Nat Rev Cancer 2022. [PMID: 35264777 DOI: 10.1038/s41568-022-00454-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Rahman MA, Park MN, Rahman MH, Rashid MM, Islam R, Uddin MJ, Hannan MA, Kim B. p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets. Front Cell Dev Biol 2022;10:761080. [DOI: 10.3389/fcell.2022.761080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
4 Xia Z, Kon N, Gu AP, Tavana O, Gu W. Deciphering the acetylation code of p53 in transcription regulation and tumor suppression. Oncogene 2022. [PMID: 35487975 DOI: 10.1038/s41388-022-02331-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Koulgi S, Achalere A, Sonavane U, Joshi R. Markov State Modeling Analysis Captures Changes in the Temperature-Sensitive N-Terminal and β-Turn Regions of the p53 DNA-Binding Domain. J Chem Inf Model 2022. [PMID: 35614540 DOI: 10.1021/acs.jcim.2c00380] [Reference Citation Analysis]
6 Mandal R, Kohoutova K, Petrvalska O, Horvath M, Srb P, Veverka V, Obsilova V, Obsil T. FOXO4 interacts with p53 TAD and CRD and inhibits its binding to DNA. Protein Science 2022;31. [DOI: 10.1002/pro.4287] [Reference Citation Analysis]
7 Liang J, Guan X, Bao G, Yao Y, Zhong X. Molecular subtyping of small cell lung cancer. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.05.010] [Reference Citation Analysis]
8 Vertecchi E, Rizzo A, Salvati E. Telomere Targeting Approaches in Cancer: Beyond Length Maintenance. Int J Mol Sci 2022;23:3784. [PMID: 35409143 DOI: 10.3390/ijms23073784] [Reference Citation Analysis]
9 Chen X, Wang S, Zhang L, Yuan S, Xu T, Zhu F, Zhang Y, Jia L. Celastrol Inhibited Human Esophageal Cancer by Activating DR5-Dependent Extrinsic and Noxa/Bim-Dependent Intrinsic Apoptosis. Front Pharmacol 2022;13:873166. [PMID: 35754502 DOI: 10.3389/fphar.2022.873166] [Reference Citation Analysis]
10 Degn K, Beltrame L, Dahl Hede F, Sora V, Nicolaci V, Vabistsevits M, Schmiegelow K, Wadt K, Tiberti M, Lambrughi M, Papaleo E. Cancer-related Mutations with Local or Long-range Effects on an Allosteric Loop of p53. J Mol Biol 2022;:167663. [PMID: 35659507 DOI: 10.1016/j.jmb.2022.167663] [Reference Citation Analysis]
11 Teng D, Xia S, Hu S, Yan Y, Liu B, Yang Y, Du X, Khan R. miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression. Computational Intelligence and Neuroscience 2022;2022:1-13. [DOI: 10.1155/2022/7179733] [Reference Citation Analysis]
12 Kung C, Weber JD. It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy. Front Cell Dev Biol 2022;10:818744. [DOI: 10.3389/fcell.2022.818744] [Reference Citation Analysis]
13 Panatta E, Zampieri C, Melino G, Amelio I. Understanding p53 tumour suppressor network. Biol Direct 2021;16:14. [PMID: 34362419 DOI: 10.1186/s13062-021-00298-3] [Reference Citation Analysis]
14 Chen D, Chu B, Yang X, Liu Z, Jin Y, Kon N, Rabadan R, Jiang X, Stockwell BR, Gu W. iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4. Nat Commun 2021;12:3644. [PMID: 34131139 DOI: 10.1038/s41467-021-23902-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zhang M, Yang Q, Zhu Y, Zhang Y, Zhang R, Liu J, Zhao X, Dang Q, Huang D, Zhang M, Wei Y, Hu Z, Cai X, Gao L, Shan Y, Yu H. Nobiletin Inhibits Hypoxia-Induced Placental Damage via Modulating P53 Signaling Pathway. Nutrients 2022;14:2332. [DOI: 10.3390/nu14112332] [Reference Citation Analysis]
16 Murnyak B, Huang LE. Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma. Cells 2021;10:2116. [PMID: 34440884 DOI: 10.3390/cells10082116] [Reference Citation Analysis]
17 Zhou S, Fan C, Zeng Z, Young KH, Li Y. Clinical and Immunological Effects of p53-Targeting Vaccines. Front Cell Dev Biol 2021;9:762796. [PMID: 34805170 DOI: 10.3389/fcell.2021.762796] [Reference Citation Analysis]
18 Luo D, Yu C, Yu J, Su C, Li S, Liang P. p53-mediated G1 arrest requires the induction of both p21 and Killin in human colon cancer cells. Cell Cycle 2021;:1-12. [PMID: 34878965 DOI: 10.1080/15384101.2021.2014249] [Reference Citation Analysis]
19 Jiménez A, Lu D, Kalocsay M, Berberich MJ, Balbi P, Jambhekar A, Lahav G. Time‐series transcriptomics and proteomics reveal alternative modes to decode p53 oscillations. Molecular Systems Biology 2022;18. [DOI: 10.15252/msb.202110588] [Reference Citation Analysis]
20 Guardia T, Eason M, Kontrogianni-Konstantopoulos A. Obscurin: A multitasking giant in the fight against cancer. Biochim Biophys Acta Rev Cancer 2021;1876:188567. [PMID: 34015411 DOI: 10.1016/j.bbcan.2021.188567] [Reference Citation Analysis]
21 Wang CY, Chao CH. p53-Mediated Indirect Regulation on Cellular Metabolism: From the Mechanism of Pathogenesis to the Development of Cancer Therapeutics. Front Oncol 2022;12:895112. [PMID: 35707366 DOI: 10.3389/fonc.2022.895112] [Reference Citation Analysis]
22 Elwakeel A. Abrogating the Interaction Between p53 and Mortalin (Grp75/HSPA9/mtHsp70) for Cancer Therapy: The Story so far. Front Cell Dev Biol 2022;10:879632. [DOI: 10.3389/fcell.2022.879632] [Reference Citation Analysis]
23 Guarnaccia L, Navone SE, Masseroli MM, Balsamo M, Caroli M, Valtorta S, Moresco RM, Campanella R, Schisano L, Fiore G, Galiano V, Garzia E, Appiani GC, Locatelli M, Riboni L, Marfia G. Effects of Metformin as Add-On Therapy against Glioblastoma: An Old Medicine for Novel Oncology Therapeutics. Cancers 2022;14:1412. [DOI: 10.3390/cancers14061412] [Reference Citation Analysis]
24 Kitakata H, Endo J, Ikura H, Moriyama H, Shirakawa K, Katsumata Y, Sano M. Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis. Int J Mol Sci 2022;23:1414. [PMID: 35163335 DOI: 10.3390/ijms23031414] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhu Z, Song M, Li W, Li M, Chen S, Chen B. Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma. Front Oncol 2021;11:695001. [PMID: 34616672 DOI: 10.3389/fonc.2021.695001] [Reference Citation Analysis]
26 Bieging-Rolett KT, Attardi LD. Zmat3 splices together p53-dependent tumor suppression. Mol Cell Oncol 2021;8:1898523. [PMID: 34027039 DOI: 10.1080/23723556.2021.1898523] [Reference Citation Analysis]
27 Wang X, Wang Y, Li Z, Qin J, Wang P. Regulation of Ferroptosis Pathway by Ubiquitination. Front Cell Dev Biol 2021;9:699304. [PMID: 34485285 DOI: 10.3389/fcell.2021.699304] [Reference Citation Analysis]
28 Chen V, Bo C, Gu W. The roads to ferroptosis under homeostatic versus pathological conditions. Mol Cell Oncol 2021;8:1970477. [PMID: 34859139 DOI: 10.1080/23723556.2021.1970477] [Reference Citation Analysis]
29 Liu Y, Gu W. p53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death Differ 2022. [PMID: 35087226 DOI: 10.1038/s41418-022-00943-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Huang Y, Sheng H, Xiao Y, Hu W, Zhang Z, Chen Y, Zhu Z, Wu D, Cao C, Sun J. Wnt/β-catenin inhibitor ICG-001 enhances the antitumor efficacy of radiotherapy by increasing radiation-induced DNA damage and improving tumor immune microenvironment in hepatocellular carcinoma. Radiother Oncol 2021;162:34-44. [PMID: 34214613 DOI: 10.1016/j.radonc.2021.06.034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Foth M, McMahon M. Autophagy Inhibition in BRAF-Driven Cancers. Cancers (Basel) 2021;13:3498. [PMID: 34298710 DOI: 10.3390/cancers13143498] [Cited by in F6Publishing: 1] [Reference Citation Analysis]